NICHE-HGG Trial: A randomised pilot trial of Neoadjuvant checkpoint Inhibition followed by Combination adjuvant checkpoint inHibition in childrEn and young adults with recurrent or progressive High Grade Glioma.

  • Gottardo, Nicholas G. (Primary Chief Investigator (PCI))
  • Mueller, Sabine (Chief Investigator (CI))
  • Ziegler, David (Chief Investigator (CI))
  • Strong, Robyn (Chief Investigator (CI))
  • Jones, Janelle (Chief Investigator (CI))
  • May, Kylie (Project Manager)

Project: Research

Project Details

Short titleNICHE-HGG
StatusActive
Effective start/end date1/01/21 → 30/06/26